Schroth & Schroth LLC
The Link Between Zantac and Cancer
Use of the recalled heartburn drug Zantac and generic ranitidine has been linked to an increased risk of cancer due to exposure to the carcinogenic substance N-nitrosodimethylamine (NDMA). Since Zantac (ranitidine) was introduced to the market in the early 1980s, millions of people have taken the drug to treat or prevent symptoms of heartburn, acid indigestion, gastroesophageal reflux disease (GERD), and ulcers of the stomach and intestines.